#pharmaceutical company website

[chemxpert]

The Rise of Digital Health: France's Journey to Healthcare Innovation

More to the future of digital health in France , there is much hope. For the future with progressing and developing technologies France remains in strategic conditions to become one of leaders among digital health industries with great government backing, innovative effects and experienced staff.

[happywebdesign]

The Bettering Company

[arogyaaushadhi]

Medications Without Prescription: Access Quality Healthcare with Arogya Aushadhi

In today’s fast-paced world, accessing healthcare has become more convenient with the rise of online pharmacies. At Arogya Aushadhi, we understand the need for affordable and accessible medication. With our platform, you can easily get medications without prescription for common ailments, ensuring you have quick access to the medicines you need.

Here’s why Arogya Aushadhi stands out:

Wide Range of Medicines: We offer an extensive selection of over-the-counter (OTC) medications that don’t require a prescription. From pain relievers to allergy medicines, our inventory ensures that you find the right product for your needs.

Affordable Prices: At Arogya Aushadhi, we believe in providing high-quality medicines at competitive prices. Our affordable rates ensure you don’t break the bank while caring for your health.

Convenient Ordering: Our user-friendly website makes it easy to browse, select, and order medications in just a few clicks. Enjoy the convenience of home delivery across India.

Trusted Quality: All products available on our platform go through strict quality checks to ensure that you receive only safe and effective medications.

Expert Guidance: Unsure about what you need? Our platform provides helpful information to guide you toward the best choices for your symptoms and requirements.

With Arogya Aushadhi, managing your health has never been easier. Whether you’re looking for a quick remedy for a headache or regular supplements, we’re here to provide hassle-free access to medications without prescription.

Contact Information:

Address: Ground Floor, 20/DK-4, Annexie, Danish Kunj, Kolar Road, Bhopal, MP - 462042

Phone: +91 9826137122

Website: Arogya Aushadhi

Experience a seamless way to maintain your health with Arogya Aushadhi today!

[thoughtportal]

Opinion Here’s how to get free Paxlovid as many times as you need it

When the public health emergency around covid-19 ended, vaccines and treatments became commercial products, meaning companies could charge for them as they do other pharmaceuticals. Paxlovid, the highly effective antiviral pill that can prevent covid from becoming severe, now has a list price of nearly $1,400 for a five-day treatment course.

Thanks to an innovative agreement between the Biden administration and the drug’s manufacturer, Pfizer, Americans can still access the medication free or at very low cost through a program called Paxcess. The problem is that too few people — including pharmacists — are aware of it.

I learned of Paxcess only after readers wrote that pharmacies were charging them hundreds of dollars — or even the full list price — to fill their Paxlovid prescription. This shouldn’t be happening. A representative from Pfizer, which runs the program, explained to me that patients on Medicare and Medicaid or who are uninsured should get free Paxlovid. They need to sign up by going to paxlovid.iassist.com or by calling 877-219-7225. “We wanted to make enrollment as easy and as quick as possible,” the representative said.

Indeed, the process is straightforward. I clicked through the web form myself, and there are only three sets of information required. Patients first enter their name, date of birth and address. They then input their prescriber’s name and address and select their insurance type.

All this should take less than five minutes and can be done at home or at the pharmacy. A physician or pharmacist can fill it out on behalf of the patient, too. Importantly, this form does not ask for medical history, proof of a positive coronavirus test, income verification, citizenship status or other potentially sensitive and time-consuming information.

But there is one key requirement people need to be aware of: Patients must have a prescription for Paxlovid to start the enrollment process. It is not possible to pre-enroll. (Though, in a sense, people on Medicare or Medicaid are already pre-enrolled.)

Once the questionnaire is complete, the website generates a voucher within seconds. People can print it or email it themselves, and then they can exchange it for a free course of Paxlovid at most pharmacies.

Pfizer’s representative tells me that more than 57,000 pharmacies are contracted to participate in this program, including major chain drugstores such as CVS and Walgreens and large retail chains such as Walmart, Kroger and Costco. For those unable to go in person, a mail-order option is available, too.

The program works a little differently for patients with commercial insurance. Some insurance plans already cover Paxlovid without a co-pay. Anyone who is told there will be a charge should sign up for Paxcess, which would further bring down their co-pay and might even cover the entire cost.

Several readers have attested that Paxcess’s process was fast and seamless. I was also glad to learn that there is basically no limit to the number of times someone could use it. A person who contracts the coronavirus three times in a year could access Paxlovid free or at low cost each time.

Unfortunately, readers informed me of one major glitch: Though the Paxcess voucher is honored when presented, some pharmacies are not offering the program proactively. As a result, many patients are still being charged high co-pays even if they could have gotten the medication at no cost.

This is incredibly frustrating. However, after interviewing multiple people involved in the process, including representatives of major pharmacy chains and Biden administration officials, I believe everyone is sincere in trying to make things right. As we saw in the early days of the coronavirus vaccine rollout, it’s hard to get a new program off the ground. Policies that look good on paper run into multiple barriers during implementation.

Those involved are actively identifying and addressing these problems. For instance, a Walgreens representative explained to me that in addition to educating pharmacists and pharmacy techs about the program, the company learned it also had to make system changes to account for a different workflow. Normally, when pharmacists process a prescription, they inform patients of the co-pay and dispense the medication. But with Paxlovid, the system needs to stop them if there is a co-pay, so they can prompt patients to sign up for Paxcess.

Here is where patients and consumers must take a proactive role. That might not feel fair; after all, if someone is ill, people expect that the system will work to help them. But that’s not our reality. While pharmacies work to fix their system glitches, patients need to be their own best advocates. That means signing up for Paxcess as soon as they receive a Paxlovid prescription and helping spread the word so that others can get the antiviral at little or no cost, too.

{source}

[staytinyville]

Stay Alive (1)

BTS ot7 x Reader

Magical Creatures AU

Series Masterlist

Warnings: None

A/N I am very excited for this story! It has a good amount of world building that I enjoy doing so much! I took inspiration from Stay Alive by Jungkook/Suga in case you guys didn’t know! The beginnings are of course slow but that’s how most stories are to build up the tension. I hopeful for this story and I hope you all like it! Please feel free to ask if you want to be added to the taglist!

People walk among the same earth constantly. However the thing that sets us apart is the path we all take. Sometimes it's the same, other times it's the opposite. Some of us are meant for higher things while some are meant to suffer until things start to look up for us all. 

In a lifetime sometimes we won’t ever get the chance to see ourselves reach the peak we want. There are struggles we all face that will cause setbacks in the path we are taking. Only the ones who are strong enough to see the road to the end make it out alive. 

There will always be those out there who will achieve their goals in life some way or another. Those are the ones who don’t allow those setbacks to dictate their entire life. And maybe along the way someone will come along to help you grow stronger. Whether it’s one person or a whole group. You will see to the end of your path one way or another. 

“Most often than not you will be working on filing. If we are understaffed on a day, like today, we might send you in to write reports on the medicine we have already administered.” Suho, the lady who was placed as your preceptor, explained to you.

You had a grateful smile on your face, happy to finally get to start working. While it wasn’t the place you had been hoping for, you knew the pay was well for the kind of student debts you had. The pharmaceutical lab was meant to administer different kinds of medicines to the people who would sign up for a trial. They did the test on patients before they were given out to people. 

While you were being placed on the front desk for the most part, you knew you would need to work your way up to the spot you wanted and you were more than happy to reach for it. 

“What kind of medicine do you guys make?” You asked, trying to think about all that you had read on the company's website. 

It didn’t really give much about what they focus on so you found it really odd that they were so wide when it came to the things they were trying to cure. 

“You applied here and don't even know?” Suho frowned, looking at you appalled.

“I tried asking at the interview but they just gave me vague answers.” You explained. “The website doesn't tell you anything either.”

“We are very on top of the things we do here at HYBE.” She began to tell you. “There aren’t many people we trust to be hired onto the team so consider yourself lucky to be apart of it.”

“We make sure that our patients here are taken care of because we are a company that is trying hard to reach their goals. Because of that we are detail oriented when it comes to the patients we accept. Not just anyone can be a patient here.” 

While she did a bit more about the kind of company you were working at, it still didn’t really tell you about what it was you were working for. You didn’t choose to question it, knowing that the paycheck they gave you was a luxury for a lot of people. 

“Here are some of your patients for the day. They have already been given the medicine, it's up to you to check up on them for daily research.” You took the six files the lady handed you, nodding your head. 

You placed them onto the small desk area they had given you before going through them to check on the appointment times and ordering them correctly. The first one on your list should be waiting in the lobby by now so you were quick to take the papers and move along to the waiting room.

“Mrs. Han?” You called, a smile on your face. 

An older woman with a younger one came to a stand, slowly shuffling over to where you waited for them at the door. 

“Hello, Mrs. Han. How are you today?” You asked politely, leading the two women towards the scale. 

“I'm doing great! I'm so excited to share some news about the medicine you gave me.” The older woman exclaimed, a bright smile on her face. 

You hummed, keeping the friendly look as you wrote down her weight on the paper. You told them to follow you to a patient room to speak to her privately. 

“I see it was something for your dementia.” You spoke, moving the laptop in the room closer so you could take down everything the lady would tell you. “Is everything going okay?”

“It's wonderful!” The other lady exclaimed for her mother. At least you assumed it was her daughter from the notes that people already had written for you. Her daughter was the one who was in charge of all Mrs. Han’s things.

“You would not believe it but it's almost as though she's regressed in her illness! Mother was in a terrible state when she was offered this trial medicine. She took it and suddenly it was almost like she went back to before it grew to be terrible.”

You tried to write down what the woman was saying, but you knew there were more questions to ask before concluding the entire meeting. 

“Maybe she can get back to normal if she takes more.” The daughter spoke in a hopeful tone. 

“One step at a time, Mrs. Byun.” You kept the smile on your face so as to not let them think they weren’t going to find the help they needed. “We have to see how long this medicine will last first before giving her more doses.” You explained.

“Also, memory loss is nothing to be overly worried about if it's on occasion. Even I forget something's as well.” You told them. 

If there was one thing you studied, it was medicine. You knew the consequences of taking too much or too little. This company was in the slow movement of developing them so they had to be careful about how they administered their projects. People probably came in thinking they could get more if they worked perfectly the first time. However these kinds of things were tests, not the real deal.

“Of course.” Mrs. Byun nodded in understanding. 

The rest of the visit went by smoothly as you took down all the older woman’s rants and aches about the whole thing. With these kinds of surveys it was really about asking how each patient felt even if it was the smallest of things. You wouldn’t be able to tell if it had to do with the medicine or with something else.

As you told Mrs. Han and her daughter goodbye, scheduling the next appointment, the rest of you patient trickled in one-by-one. 

There was a man who had come in for a bad liver–he was an avid drinker–so the medicine was for corrosion to that organ. While you really tried not to say something about it, you felt annoyed that the man had explained that he still had a drink every once in a while. He was like Mrs. Han, the medicine was doing wonders. 

There was a child who had chickenpox, who’s mother explained that the rash that had taken over her son’s body was slowly dwindling down. Another lady who had come in for amnesia which only said that her memory was returning to before she had gotten into an accident. The others had external injuries like scrapes of their knees or a deep cut that needed stitches. From what you could see they were just given some sort of pain medication. They had expressed that their wounds didn’t hurt and it was actually healing at a fast rate. 

“They really work with a lot of medicine.” You spoke to yourself as you looked over the last file you had. You frowned your eyebrows when you saw the patient was in another level of the building. It was the lower levels, which meant in the basement of sorts. From what you knew that was where the labs were. 

“That's odd.” You tilted your head in confusion but made your way over to the elevators anyway. With your ID card, you pressed onto one of the underground levels, leaning back against the metal wall. When the doors opened, you were met with a lobby that had a couple of different doctors moving about. 

Following the signs, you found the door that led to some of the rooms patients were stationed in. You showed the security guard your ID explaining you were in that level of the building to check up on a patient. He took a look at the file you had in your hand, humming as he opened a door to the back for you. 

Overlooking the file once more to make sure you had the right number, you quietly counted the doors. As you passed by one, you felt a shiver go down your back causing you to halt in your tracks. The number three stared back at you as a weird feeling flowed over your shoulders. It felt like something was brushing up against them, pushing at your form. 

You quickly turned back around making your way to the room next to it. You checked over the file one more time. It didn’t really give you much about the medicine the patient had been given. All it said was that they were someone who was meant to be staying in the building for better observation. There were a couple of papers that you seemed to be missing, you noticed.

Before opening the door, you knocked politely. “Hello?” You softly called as you stuck your head in. 

The only light on was the bedside lamp which illuminated the dark room. You frowned at the aspect of there being no windows that would allow light from outside to come in. As you walked in closer, you let go of the door to have it shut by itself. “Mr. Jeon?”

“Who are you?” You gasped, nearly tripping on your feet from the hard flinch you felt take over. 

You took in the man who was standing behind you, trying to regulate your breathing. He only looked at you with a raised brow, his expression passive. You took up his large form, noticing the blue scrubs he wore were almost tight around his physic. He didn’t wear any shoes–was even foregoing to wear socks. 

“Oh,” You said as your breath returned to your lungs. “My name is (Y/N). Today is my first day so I guess I'll be your new nurse.” You explained to him.

“What are you doing here?” As he took a step closer to you, you subconsciously took one back. “You don't deserve to be here.” His voice went quiet as his eyes turned soft. 

Your eyebrows furrowed as you took in his worried expression, smiling awkwardly as you patted your hands to wipe the sweat forming on them. 

“I needed a job. Got school debt to pay off.” You tried to joke with him. He looked too serious, which made you anxious to touch him for his vitals. “I'm here to do a check up. Would you mind?” You asked, trying to build up the courage to get close to him. 

He didn’t say anything, just poked his cheek with his tongue, moving to the bed. You smiled in thanks, looking around the room to find the equipment needed. You purse your lips when you realize you would need to check his heart rate manually. Finding the padding needed to place around his arm, you made your way over to the man.

He flinched back as your hands moved to touch his arm, causing you to stop. “I’m going to check your heart rate.” You explained, remembering that you were the kind of person to make sure people knew what it was you were going to do. 

As he kept his dark eyes on you, he allowed you to softly touch his scrub sleeve as you moved the fabric up to place the padding in the right area of the arm. You moved your stethoscope from around your neck. “It’s going to be a bit cold.” You whispered. 

As you moved on with the check up, you watched the numbers on the dial move carefully counting to yourself. When you finished getting what you needed, you quickly let go of the air and moved the padding off his arm. As you did that, your eyes seemed to blur over the ink the man had. 

Your fingers gently squeezed his bicep, softly moving down the length of his arm. Your gaze drifted over each color and picture the man had, trying to figure out where one picture ended and the next started. As your fingers glided over his pulse on his wrists, the man involuntarily shivered at the touch. 

“Sorry.” You quickly pulled back, looking back up at him. “Your tattoos are really nice. I've never seen so many.” You bashfully smiled at him. 

He only looked at you curiously, his big eyes taking in your facial expressions. It made you feel flustered as he looked at you so deeply, causing you to lick your lips and look away. 

“You have a very strong heart. Very good blood flow.” You told him, turning away to write down his vitals. He slowly got off the bed and moved closer to you. 

“It doesn't say which medicine you've been taking which is really weird.” You frowned, looking over all the papers that you were given. There were some things missing but you assumed the high ups were looking over it. 

“You're different.” You jumped at the voice that spoke directly behind you. Turning around you tilted your head up at the man.

“How so?” You asked.

“You're nice.” The boy squinted his eyes at you, like he was trying to figure you out.

“Are the others not?” You frowned.

“Not the ones who come down here.” He told you.

You tried to quickly cover up your upset expression, looking up at the doe-eyed man with a smile. “Well I hope I'm able to come down here again.” You took up the paper you had written on. There wasn’t much explanation on what you had to ask him so you chose to go back up and see if you could figure out what else to do.

“Have a good day, Mr. Jeon.” You smiled brightly, waving from the door.

Jungkook tilted his head to the side as a warmth spread through his chest from your words. Not a day had gone by that he wasn't thinking about the dreaded place as though it was a sentence in hell. He had never met someone like you; someone who spoke to him as though he too was a person.

It made him light headed to think about the way your words affected him. He couldn't think of the last time someone had ever uttered those kinds of words to him. It had been so long-alone thinking this was what life was going to be like for the rest of his life. But suddenly things changed in the blink of an eye.

“Maybe.”

Series Masterlist

[medusapelagia]

S - Soulmate

S is for Sage (@cranberrymoons) I swear I tried to write some fluff but I wasn't able to! I still have to learn from you! Thank you for your kindness💜

I hope you will enjoy your present 🎁!

Rating: Mature Relationship: Steve /Eddie WT: needles, hospitals, car accident Words: 1145

Steve sighs for the umpteenth time, wondering why in the hell he should have been born as the only son of Richard and Margaret Harrington and being used as a test subject for their latest crazy idea.

Being the owner of a big pharmaceutical company they were always eager to show Steve what they had come up with, especially when their last invention was a machine that was able to predict who your soulmate was: all you had to do was give a tiny drop of blood to the machine and it would have found your perfect match.

No more apps or websites, no more awful first date! Find your soulmate now!

That is the spot that keeps going on the television in the waiting room, and now Steve is sitting in a waiting area, ready to be pinched and find his soulmate. Not that he was really looking forward to it, but his girlfriend just broke up with him and his mum was adamant that the machine would have found Steve's perfect match avoiding more suffering, and in the end, Steve has agreed to be a test subject.

“It will be ok.” his mother tells him while lifting the collar of his shirt.

They aren’t allowed to test the machine on a minor without the parents' approval so Steve is going to be the first minor tested “You don’t have to worry, the machine will find the perfect match for you, isn’t that what everyone wants?” his mother asks him, before gently pushing him toward a nice nurse and Steve suppresses the desire to ask her if she has taken the test and if his father is actually her soulmate or not. He probably is not, Steve already knows that since the first time that his father punched the door and his mother threw him a few plates.

"If your soulmate has ever been to a hospital, the machine can match their blood results with yours and give us a name." the nurse is saying to Steve while she helps him on the examination table.

"Mum says it only has data from the USA." Steve states monotone, while he tries to keep his mind focused and not worry about what would happen if his soulmate is from another country or even worse, dead.

The smile on the nurse's face falters a little "That's true, but I'm confident that a young boy like you will find the proper match in no time." she insists, pinching his finger and putting the data in the machine.

He thanks her and goes back to the waiting area where his parents are waiting for him and the three of them stare at the numbers on the screen looking at the countdown and waiting for the number one, followed by a name, but the machine doesn't stop at one.

It stops at zero.

No match.

This could mean that either Steve's soulmate has never been to a hospital, and that’s why there are no records to match, or that he is not from the USA, or… that he is not alive anymore.

It’s not bad, he doesn’t even know their name so he can’t mourn someone that he never knew, right?

"I'm sure that's a mistake, honey, you can retake the test when you want." his mum assures him.

He takes the test another three times, always with the same result: zero.

***

Steve’s parents have become even richer thanks to the technology of the soulmating machine; somehow people are willing to know who their true soulmate is and it doesn’t matter if some family broke after they get the result, they keep going to the center and being tasted again, and again, and again.

Steve doesn't believe in soulmates anymore, and when Dustin asks him if he should be tested to know if Suzy is his soulmate Steve firmly denies him access telling him that he is far too young and that it doesn’t matter the name of a stupid machine, what matter is how he feels and if he loves Suzy that’s more than enough.

Dustin doesn’t seem convinced but he doesn’t ask again to be tasted and Steve takes it as a win, at least until he receives a call from a crying Dustin.

“There was an accident.” the kid says between the tears “Eddie was driving, then a dog appeared from nowhere and Eddie tried to avoid it and we crashed.”

“Are you ok?” Steve asks worriedly, already taking his car keys and his jacket.

“The ambulance came and they brought us to the hospital. My mum is at work and I didn’t know who to call.”

“You did good Dustin, don’t worry I’m coming to get you.” Steve replies, trying to calm the kid.

“But Eddie…”

“He will be ok. I’m sure he will.”

“You haven’t seen him. He had blood all over his face…” Dustin continues while Steve gets in the car and continues to talk to the boy until he finally gets to the hospital; Dustin is still on his phone, talking to Steve who is just a few feet away, when he sees him he lets the phone drop and runs toward him, hugging him tight.

Steve holds him until the kid stops crying, and then they go to ask for some information from the staff.

“He has no health insurance.” someone tells him and Steve throws a platinum card with his name in big bold letters “Now he does.” he states and then comes back to Dustin. Steve doesn’t really like Eddie, he is a little bit jealous, to be honest, but he is Dustin’s friend and Steve’s family has so much money that paying for Eddie’s care is not a problem.

“Come with me.” he says to Dustin “I know for sure that the cafeteria has the best hot chocolate ever.”

The hot chocolate comforts Dustin enough that he finally falls asleep on Steve’s shoulder. The boy calls Claudia, telling her that they are at the hospital, that Dustin is fine, but that he has to wait to have news about their friend, and the woman gets to the hospital as fast as she can “Are you sure you want to stay here? We don’t know how long it will take to have any information.” Claudia asks Steve before waking up Dustin but Steve nods “Someone has to stay until his uncle arrives and Dustin already had a difficult day.”

The woman nods and after a few complaints, Dustin agrees to go back home, promising that he will be back in the morning.

Steve nods and finally goes to grab a coffee at the coffee machine; he has just pushed the button when his phone starts to vibrate and he tiredly takes a look at the notifications: it’s the soul-matching app.

He got a match.

His name is Eddie Munson.

[covid-safer-hotties]

Reference archived on our website (Daily updates! Thousands of articles, studies, and resources at your fingertips!)

Abstract Though scientific consensus regarding HIV causation of AIDS was reached decades ago, denial of this conclusion remains. The popularity of such denial has waxed and waned over the years, ebbing as evidence supporting HIV causation mounted, building again as the internet facilitated connection between denial groups and the general public, and waning following media attention to the death of a prominent denier and her child and data showing the cost of human life in South Africa. Decades removed from these phenomena, HIV denial is experiencing another resurgence, coupled to mounting distrust of public health, pharmaceutical companies, and mainstream medicine. This paper examines the history and current state of HIV denial in the context of the COVID pandemic and its consequences. An understanding of the effect of this phenomenon and evidence-based ways to counter it are lacking. Community-based interventions and motivational interviewing may serve to contain such misinformation in high-risk communities.

[transmutationisms]

im beginning to explore antipsych but do you think it would be worth it to study psychiatry first? like look at the textbooks they give undergrads, the dsm 5 etc. (and if so do you have any recs for introduction texts to psychology lol)

this will entirely depend on what specific types of questions you're trying to answer. textbooks in particular will speak to some questions (the way the field presents itself to students; the official ie guild-determined consensus on key issues) but not others (how practitioners actually think and practice, what ethical violations are occurring in practice, how patients understand their own diagnoses and treatment experiences, what practitioners are being taught from sources like pharmaceutical reps or professional conferences). you should also be attentive to local and temporal distinctions, meaning, think about what specific time period and place you're interested in (& a text is speaking about) as you try to synthesise different texts and ideas; this sort of historical awareness will also affect what (if any) primary sources you're interested in from both the psych and antipsych camps. if you do want to read current psy-science textbooks, here is what i would recommend: do a few minutes of research into what the top (meaning, most frequently used) psych textbook companies are in the country or countries you're interested in; figure out what titles they sell (you can usually do this on a publisher's website); and then track down free versions online. again, though, whether this is a valuable exercise depends heavily on what you're trying to find and what sorts of questions you're asking. as a matter of general comprehensibility, most antipsych literature will make at least a cursory attempt to summarise and explain the psych positions it's arguing against (there are some useful books that do this wrt dsm diagnoses in this list), and there are also other sorts of documents and sources you may want to investigate if you're trying to understand psychiatry beyond its very theoretical presentation in an undergrad context.

[azspot]

He's anti-mask. He's anti-vaccine. He's anti-public health. He's all of these things, while investing heavily in pharmaceutical companies that treat infectious diseases and chronic health conditions. He's a venture capitalist with a law degree, a writer who preaches the same kind of bootstrapping grit that drips off the internet's self-help websites. He's friends with bunker-building billionaires like Peter Thiel.

What We All Need to Know About J.D. Vance

[ridenwithbiden]

I'M ONE OF THE "WASTEFUL EXPENDITURES" THEY WILL CUT.

The incoming Trump administration’s solution to government spending is a NEW Department of Government Efficiency led by co-department (2 NEW) CHIEFS: the world’s richest man and Trump’s former political opponent.

But while on the surface the plan to cut government spending seems simple, the “department,” led by multibillionaire Elon Musk and former Republican presidential candidate Vivek Ramaswamy is fairly unorthodox. The U.S. Constitution states the President: “may require the Opinion, in writing, of the principal Officer in each of the executive Departments.” That section implies a primary leader and explains why the 15 executive Cabinet departments including State, Defense, and Treasury have a single secretary with a chain-of-command from the President on down. However, other agencies, like the Federal Trade Commission, are governed by a commission structure; the President taps one commissioner to serve as chair.

What is it? In a statement on Truth Social Tuesday, president-elect Donald Trump gave the department a broad mandate to “dismantle Government Bureaucracy, slash excess regulations, cut wasteful expenditures, and restructure Federal Agencies.” Trump compared the department’s importance to that of the “Manhattan Project” which led to the creation of the atomic bomb in the 20th century.

Trump added in the statement that the co-leaders would target waste and fraud that Trump said exists throughout the $6.5 trillion yearly federal budget. The department will operate through July 4, 2026, wrapping up its operations just in time for the 250th anniversary of the Declaration of Independence, Trump said in the statement.

Co-leader Elon Musk said in a Wednesday post that the massive cuts and reforms “will be done much faster.”

Why two department heads? Both leaders of the department, multibillionaire Elon Musk and former Republican presidential candidate Vivek Ramaswamy, have been avid supporters of the president-elect. Musk, the CEO of Tesla and SpaceX and the owner of social media website X, reportedly supported Trump via his super PAC with about $200 million in funding and often spoke with him at campaign rallies leading up to the election. Musk is the richest man in the world, with a net worth of $319 billion, according to the Bloomberg Billionaires Index.

Although he ran against Trump in the Republican primary race, Ramaswamy dropped out and endorsed Trump in January. The entrepreneur, who founded pharmaceutical company Roivant Sciences, has also appeared with Trump on the campaign trail.

Some leaders of the democratic party have already criticized the co-leaders of the department, including Sen. Elizabeth Warren (D-Mass.).

“The Office of Government Efficiency is off to a great start with split leadership: two people to do the work of one person. Yeah, this seems REALLY efficient,” Warren wrote in a Tuesday post on X.

The Trump transition team did not immediately respond to Fortune’s request for comment.

Will the Department of Government Efficiency be a new government department? Contrary to its name, the new “department” will not be a part of the federal government, but rather more like a consulting arm that “will provide advice and guidance from outside of Government,” according to the statement. Musk flagged the fact that the new department exists outside of the government as “important details” in a post on X Wednesday. Musk especially has his hands full elsewhere with his other companies, Tesla, SpaceX, and social media site, X.

Despite its separation from government, the department’s leaders have Trump’s support and have pledged myriad internal changes to try to cut back on federal spending.

What have the co-leaders said about government spending? On the campaign trail with Trump, Musk said he wanted to cut the federal budget by $2 trillion, and added in an October rally that “some pretty big moves” were required.

“Our defense budget is pretty gigantic. It’s a trillion dollars,” Musk said during a rally. “The interest we owe on the debt is now higher than the defense budget. This is not sustainable. That’s why we need the Department of Government Efficiency,”

Ramaswamy has previously floated the idea of eliminating the Education Department, the FBI, and the IRS by executive order to cut spending, the New York Times reported. Ramaswamy has said the federal workforce should be cut by 75%.

The pair have said the cuts will be transparent and Musk added that the department would create a “leaderboard” to display the “most insanely dumb spending of your tax dollars.”

Will it work? Experts have cast doubt on whether Musk and Ramaswamy will be able to find $2 trillion to cut from federal spending without impacting long-untouched programs such as social security and defense spending.

The consequences of such big cuts could be massive layoffs for government employees and even some temporary economic pain. When a user on Musk’s social media site X wrote in October that Musk’s massive spending cuts could cause a temporary overreaction in the economy, Musk replied with “sounds about right.”

Former Treasury Secretary Larry Summers said in a speech at The Economic Club of New York on Tuesday that Musk would be lucky to find $200 billion worth of cuts, much less $2 trillion, CNN reported.

Why the acronym “DOGE?” The Department of Government Efficiency, or DOGE as Trump abbreviated it in his official announcement, is a callback to the meme cryptocurrency Dogecoin, which Musk has often promoted over the years.

The cryptocurrency was originally created as a joke but has grown to become the sixth largest cryptocurrency with a Wednesday market cap of $56 billion, greater than that of major companies such as Volkswagen or Ford.

The cryptocurrency jumped 20% following Trump’s announcement Tuesday and was up just over 1% on Wednesday afternoon.

[chemxpert]

Explore Global Pharma Innovations with Chemxpert Database

Discover the latest advancements in pharma exhibitions with Chemxpert Database, your go-to resource for insights into the food and drug sectors. Whether you're exploring the pharmaceutical preparation process, capsule manufacturing techniques, or seeking contract manufacturing companies in India, Chemxpert delivers a comprehensive view. Connect with top-tier pharmaceutical companies in Russia and the best pharma companies worldwide. Find a trusted pharmaceutical manufacturing company near you and stay updated with Chemxpert’s vast database.

[ikemenfangirl]

DRAMA CD : neko cafe danshi 💿 by Voltage

🐈 Love story of a cats-loving boyfriend

🐾 ดราม่าซีดี เรื่องราวความรักของแฟนหนุ่มผู้รักแมว

Title : Neko cafe danshi

Website : https://products.voltage.co.jp/nekodan/

🐈‍⬛ STORY

guys come to a cat cafe in the pouring rain.

“Would you three take care of this cats so that he gets used to our home?”

With a few words from the master, caring for the new kitten begins!?

A heartwarming and soothing story told by three guy. (and cats)

🐾 CAST

Yanagi Chiharu ：CV: Arthur Lounsbery #ランズベリーアーサー ：Product designer ：Birthday: April 26 (Age 24) ：Hight : 178 cm. ：Blood type : B ：Cat : Aoyuzu （CV : Maki Yamaichi）

Sample voice 🎧

Hibino Natauya ：CV : Ono Kensho #小野賢章 ：Pharmaceutical company seller ：Birthday: August 15 (Age 25) ：Hight : 176 cm. ：Blood type : O ：Cat : Jewel （CV : Kiri Kamasawa）

Sample voice 🎧

Kurogane Oshiro ：CV: Sato Takuya #佐藤拓也 ：President of an advertising company ：Birthday: November 17 (Age : 29) ：Hight : 182 cm. ：Blood type : AB ：Cat : Kinoko （CV : Shiori Yuzaki）

Sample voice 🎧

🛒 SH○P https://products.voltage.co.jp/nekodan/ (stellaworth, animate, amazon)

ดราม่าซีดี แฟนหนุ่มและแมว

🐈 หนุ่ม ๆ มาคาเฟ่แมวท่ามกลางสายฝน

“คุณทั้งสามช่วยดูแลเด็กคนนี้ให้เขาคุ้นเคยกับบ้านของเราได้ไหม”

ด้วยคำพูดไม่กี่คำจากเจ้าของร้าน การดูแลลูกแมวตัวใหม่จึงเริ่มต้นขึ้น!?

เรื่องราวอันอบอุ่นและผ่อนคลายที่เล่าโดยชายทั้งสาม(และแมว)

[thoughtportal]

Eli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocket 

https://www.npr.org/2023/03/01/1160339792/eli-lilly-insulin-price

Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay to fill prescriptions.

The moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live. Lilly's changes also come as lawmakers and patient advocates pressure drugmakers to do something about soaring prices.

Lilly said it will cut the list price for its most commonly prescribed insulin, Humalog, and for another insulin, Humulin, by 70% in the fourth quarter, which starts in October. The drugmaker didn't detail what the new prices would be.

List prices are what a drugmaker initially sets for a product and what people who have no insurance or plans with high deductibles are sometimes stuck paying.

Patient advocates have long called for insulin price cuts to help uninsured people who would not be affected by price caps tied to insurance coverage.

Lilly's planned cuts "could actually provide some substantial rice relief," said Stacie Dusetzina, a health policy professor at Vanderbilt University who studies drug costs.

She noted that the moves likely won't affect Lilly much financially because the insulins are older and some already face competition.

"It makes it easier for Lilly to go ahead and make these changes," she said.

Lilly also said Wednesday that it will cut the price of its authorized generic version of Humalog to $25 a vial starting in May.

The cost of a prescription for generic Humalog ranges between $44 and close to $100 on the website GoodRx.

Lilly also is launching in April a biosimilar insulin to compete with Sanofi's Lantus.

Lilly CEO David Ricks said in a statement that it will take time for insurers and the pharmacy system to implement its price cuts, so the drugmaker will immediately cap monthly out-of-pocket costs at $35 for people who are not covered by Medicare's prescription drug program.

The drugmaker said the cap applies to people with commercial coverage and at most retail pharmacies.

Lilly said people without insurance can find savings cards to receive insulin for the same amount at its InsulinAffordability.com website.

The federal government in January started applying that cap to patients with coverage through its Medicare program for people age 65 and older or those who have certain disabilities or illnesses.

American Diabetes Association CEO Chuck Henderson said in a statement he applauded the steps Lilly was taking and called for other insulin makers to also cap patient costs.

Aside from Eli Lilly and the French drugmaker Sanofi, other insulin makers include the Danish pharmaceutical company Novo Nordisk.

Neither company immediately responded to a request for comment Wednesday morning from The Associated Press.

Insulin is made by the pancreas and used by the body to convert food into energy. People who have diabetes don't produce enough insulin.

People with Type 1 diabetes must take insulin every day to survive. More than 8 million Americans use insulin, according to the American Diabetes Association.

Research has shown that prices for insulin have more than tripled in the last two decades, and pressure is growing on drugmakers to help patients.

President Joe Biden brought up the cost cap during his annual State of the Union address last month. He called for insulin costs for everyone to be capped at $35.

The state of California has said it plans to explore making its own cheaper insulin. Drugmakers also may face competition from companies like the nonprofit Civica, which plans to produce three insulins at a recommended price of no more than $30 a vial, a spokeswoman said.

Drugmakers may be seeing "the writing on the wall that high prices can't persist forever," said Larry Levitt, an executive vice president with the nonprofit Kaiser Family Foundation, which studies health care.

"Lilly is trying to get out ahead of the issue and look to the public like the good guy," Levitt said.

Indianapolis-based Eli Lilly and Co. became the first company to commercialize insulin in 1923, two years after University of Toronto scientists discovered it. The drugmaker then built its reputation around producing insulin even as it branched into cancer treatments, antipsychotics and other drugs.

Humulin and Humalog and its authorized generic brought in a total of more than $3 billion in revenue for Lilly last year. They rang up more than $3.5 billion the year before that.

"These are treatments that have had a really long and successful life and should be less costly to patients," Dusetzina said.

[mostlysignssomeportents]

This day in history

#20yrsago Itunes blocks you from sharing music with YOURSELF, on your own computer https://web.archive.org/web/20041009202513/http://www.raelity.org/computers/operating_systems/apple/mac_os_x/apps/itunes_single_instance.html

#20yrsago How fanfic makes kids into better writers (and copyright victims) https://www.technologyreview.com/2004/02/06/40304/why-heather-can-write/

#15yrsago Flashmob of ATM crooks scores $9 million in 49 cities https://web.archive.org/web/20090205214559/http://www.myfoxny.com/dpp/news/090202_FBI_Investigates_9_Million_ATM_Scam

#15yrsago Internet not full of pedos, the statistical edition https://www.zephoria.org/thoughts/archives/2009/02/06/doing_the_math.html

#10yrsago Turks bid farewell to the Internet in the face of brutal censorship/surveillance law https://medium.com/@ahmetasabanci/saying-goodbye-to-internet-in-turkey-33d805b98f6c

#10yrsago Middle class brands collapse, 1% brands thrive https://www.nytimes.com/2014/02/03/business/the-middle-class-is-steadily-eroding-just-ask-the-business-world.html

#10yrsago How UK spies committed illegal DoS attacks against Anonymous https://www.nbcnews.com/news/investigations/war-anonymous-british-spies-attacked-hackers-snowden-docs-show-n21361

#10yrsago Toronto’s reference library gets a makerspace https://web.archive.org/web/20140209061223/http://torontoist.com/2014/02/reference-library-unveils-3d-printers-is-cooler-than-indigo/

#10yrsago Toxic Avenger’s brilliant rant about the importance of Net Neutrality https://www.techdirt.com/2014/02/05/innovation-our-better-future-depend-preserving-net-neutrality/

#5yrsago One of pharma’s most notorious gougers is going bankrupt, but 2019 is a banner year for shkreli-grade pharmaceutical price-hikes https://arstechnica.com/science/2019/02/infamous-pharma-company-declares-bankruptcy-after-3900-price-hike/

#5yrsago Chasing down that list of potential Predpol customers reveals dozens of cities that have secretly experimented with “predictive policing” https://www.vice.com/en/article/d3m7jq/dozens-of-cities-have-secretly-experimented-with-predictive-policing-software

#5yrsago Amazon is using purchase data to sell targeted ads, which is creepy, but not because they’ve invented a mind-control ray https://memex.craphound.com/2019/02/06/amazon-is-using-purchase-data-to-sell-targeted-ads-which-is-creepy-but-not-because-theyve-invented-a-mind-control-ray/

#5yrsago The next Firefox will block all autoplayed audio, video https://hacks.mozilla.org/2019/02/firefox-66-to-block-automatically-playing-audible-video-and-audio/

#5yrsago RIP, author Carol Emshwiller https://locusmag.com/2019/02/carol-emshwiller-1921-2019/

#5yrsago Washington State sheriff used courtroom camera to zoom in on defense attorney and juror’s private notes https://www.seattletimes.com/seattle-news/san-juan-sheriffs-use-of-courtroom-camera-to-view-jurors-notebook-lawyers-notes-sparks-outrage-and-dismissal-of-criminal-case/

#5yrsago Lawsuit says that America’s “break even” court records website shouldn’t be making 98%+ profits https://www.techdirt.com/2019/02/06/multiple-parties-including-author-law-governing-pacer-ask-court-to-stop-pacers-screwing-taxpayers/

#5yrsago Fox News blames schools teaching “fairness” for support for a tax on the super-rich https://www.reddit.com/r/LateStageCapitalism/comments/annfs6/fox_news_blames_public_support_of_wealth_tax/

#1yrago Bruce Schneier's "A Hacker's Mind" https://pluralistic.net/2023/02/06/trickster-makes-the-world/#power-play

[mariacallous]

In his spare time, Tony Eastin likes to dabble in the stock market. One day last year, he Googled a pharmaceutical company that seemed like a promising investment. One of the first search results Google served up on its news tab was listed as coming from the Clayton County Register, a newspaper in northeastern Iowa. He clicked, and read. The story was garbled and devoid of useful information—and so were all the other finance-themed posts filling the site, which had absolutely nothing to do with northeastern Iowa. “I knew right away there was something off,” he says. There’s plenty of junk on the internet, but this struck Eastin as strange: Why would a small Midwestern paper churn out crappy blog posts about retail investing?

Eastin was primed to find online mysteries irresistible. After years in the US Air Force working on psychological warfare campaigns he had joined Meta, where he investigated nastiness ranging from child abuse to political influence operations. Now he was between jobs, and welcomed a new mission. So Eastin reached out to Sandeep Abraham, a friend and former Meta colleague who previously worked in Army intelligence and for the National Security Agency, and suggested they start digging.

What the pair uncovered provides a snapshot of how generative AI is enabling deceptive new online business models. Networks of websites crammed with AI-generated clickbait are being built by preying on the reputations of established media outlets and brands. These outlets prosper by confusing and misleading audiences and advertisers alike, “domain squatting” on URLs that once belonged to more reputable organizations. The scuzzy site Eastin was referred to no longer belonged to the newspaper whose name it still traded in the name of.

Although Eastin and Abraham suspect that the network which the Register’s old site is now part of was created with straightforward moneymaking goals, they fear that more malicious actors could use the same sort of tactics to push misinformation and propaganda into search results. “This is massively threatening,” Abraham says. “We want to raise some alarm bells.” To that end, the pair have released a report on their findings and plan to release more as they dig deeper into the world of AI clickbait, hoping their spare-time efforts can help draw awareness to the issue from the public or from lawmakers.

Faked News

The Clayton County Register was founded in 1926 and covered the small town of Ekader, Iowa, and wider Clayton County, which nestle against the Mississippi River in the state’s northeast corner. “It was a popular paper,” says former coeditor Bryce Durbin, who describes himself as “disgusted” by what’s now published at its former web address, claytoncountyregister.com. (The real Clayton County Register merged in 2020 with The North Iowa Times to become the Times-Register, which publishes at a different website. It’s not clear how the paper lost control of its web domain; the Times-Register did not return requests for comment.)

As Eastin discovered when trying to research his pharma stock, the site still brands itself as the Clayton County Register but no longer offers local news and is instead a financial news content mill. It publishes what appear to be AI-generated articles about the stock prices of public utility companies and Web3 startups, illustrated by images that are also apparently AI-generated.

“Not only are the articles we looked at generated by AI, but the images included in each article were all created using diffusion models,” says Ben Colman, CEO of deepfake detection startup Reality Defender, which ran an analysis on several articles at WIRED’s request. In addition to that confirmation, Abraham and Eastin noticed that some of the articles included text admitting their artificial origins. “It’s important to note that this information was auto-generated by Automated Insights,” some of the articles stated, name-dropping a company that offers language-generation technology.

When Eastin and Abraham examined the bylines on the Register’s former site they found evidence that they were not actual journalists—and probably not even real people. The duo’s report notes that many writers listed on the site shared names with well-known people from other fields and had unrealistically high output.

One Emmanuel Ellerbee, credited on recent posts about bitcoin and banking stocks, shares a name with a former professional football player. When Eastin and Abraham started their investigation in November 2023, the journalist database Muck Rack showed that he had bylined an eye-popping 14,882 separate news articles in his “career,” including 50 published the day they checked. By last week, the Muck Rack profile for Ellerbee showed that output has continued apace—he’s credited with publishing 30,845 articles. Muck Rack’s CEO Gregory Galant says the company “is developing more ways to help our users discern between human-written and AI-generated content." He points out that Ellerbee’s profile is not included in Muck Rack’s human-curated database of verified profiles.

The Register’s domain appears to have changed hands in August 2023, data from analytics service Similar Web shows, around the time it began to host its current financial news churn. Eastin and Abraham used the same tool to confirm that the site was attracting most of its readership through SEO, targeting search keywords about stock purchasing to lure clicks. Its most notable referrals from social media came from crypto news forums on Reddit where people swap investment tips.

The whole scheme appears aimed at winning ad revenue from the page views of people who unwittingly land on the site’s garbled content. The algorithmic posts are garnished with ads served by Google’s ad platform. Sometimes those ads appear to be themed on financial trading, in line with the content, but others are unrelated—WIRED saw an ad for the AARP. Using Google's ad network on AI-generated posts with fake bylines could fall foul of the company's publisher policies, which forbid content that “misrepresents, misstates, or conceals” information about the creator of content. Occasionally, sites received direct traffic from the CCR domain, suggesting its operators may have struck up other types of advertising deals, including a financial brokerage service and an online ad network.

Unknown Operator

Eastin and Abraham’s attempts to discover who now owns the Clayton County Register’s former domain were inconclusive—as were WIRED’s—but they have their suspicions. The pair found that records of its old security certificates linked the domain to a Linux server in Germany. Using the internet device search engine Shodan.io, they found that a Polish website that formerly advertised IT services appeared associated with the Clayton County Register and several other domains. All were hosted on the same German server and published strikingly similar, apparently AI-generated content. An email previously listed on the Polish site was no longer functional and WIRED’s LinkedIn messages to a man claiming to be its CEO got no reply.

One of the other sites within this wider network was Aboutxinjiang.com. When Eastin and Abraham began their investigation at the end of 2023 it was filled with generic, seemingly-AI-generated financial news posts, including several about the use of AI in investing. The Internet Archive showed that it had previously served a very different purpose. Originally, the site had been operated by a Chinese outfit called “the Propaganda Department of the Party Committee of the Xinjiang Uyghur Autonomous Region,” and hosted information about universities in the country’s northwest. In 2014, though, it shuttered, and sat dormant until 2022, when its archives were replaced with Polish-language content, which was later replaced with apparently-automated clickbait in English. Since Eastin and Abraham first identified the site it has gone through another transformation. Early this month it began redirects to a page with information about Polish real estate.

Altogether, Eastin and Abraham pinpointed nine different websites linked to the Polish IT company that appeared to comprise an AI clickbait network. All the sites appeared to have been chosen because they had preestablished reputations with Google that could help win prominence in search rankings to draw clicks.

Google claims to have systems in place to address attempts to game search rankings by buying expired domains, and says that it considers using AI to create articles with the express purpose of ranking well to be spam. “The tactics described as used with these sites are largely in violation of Search’s spam policies,” says spokesperson Jennifer Kutz. Sites determined to have breached those policies can have their search ranking penalized, or be delisted by Google altogether.

Still, this type of network has become more prominent since the advent of generative AI tools. McKenzie Sadeghi, a researcher at online misinformation tracking company NewsGuard, says her team has seen an over 1,000 percent increase in AI-generated content farms within the past year.

WIRED recently reported on a separate network of AI-generated clickbait farms, run by Serbian DJ Nebojša Vujinović Vujo. While he was forthcoming about his motivations, Vujo did not provide granular details about how his network—which also includes former US-based local news outlets—operates. Eastin and Abraham’s work fills in some of the blanks about what this type of operation looks like, and how difficult it can be to identify who runs these moneymaking gambits. “For the most part, these are anonymously run,” Sadeghi says. “They use special services when they register domains to hide their identity.”

That’s something Abraham and Eastin want to change. They have hopes that their work might help regular people think critically about how the news they see is sourced, and that it may be instructive for lawmakers thinking about what kinds of guardrails might improve our information ecosystem. In addition to looking into the origins of the Clayton County Register’s strange transformation, the pair have been investigating additional instances of AI-generated content mills, and are already working on their next report. “I think it’s very important that we have a reality we all agree on, that we know who is behind what we’re reading,” Abraham says. “And we want to bring attention to the amount of work we’ve done just to get this much information.”

Other researchers agree. “This sort of work is of great interest to me, because it’s demystifying actual use cases of generative AI,” says Emerson Brooking, a resident fellow at the Atlantic Council’s Digital Forensic Research Lab. While there’s valid concern about how AI might be used as a tool to spread political misinformation, this network demonstrates how content mills are likely to focus on uncontroversial topics when their primary aim is generating traffic-based income. “This report feels like it is an accurate snapshot of how AI is actually changing our society so far—making everything a little bit more annoying.”

[patheticmosasaur1]

today's invertebrate...........enteroxenos parastichopoli

this is the most successful thing to ever be successful and do business

it outbusinessed all the other businessmen and became so successful that it created a singularity and killed them all now it owns 30% of all the flumblos and tirples in the world, along with 5% of all social media websites, a video sharing platform, 2 now defunct moon bases, a rocket, a bigger rocket, fumbo, the keys to your house, 5 huge offices, þ, a pharmaceutical company, 8 different restaurant chains, 2 companies that produce only surfboards, the most amazing doors ever.com™, a giant oil making machine and so much more

truly the most business indeed, very immpersive and amzaingimportant business lesson!!

it owns the money, gagagsgzgagagagagagsa!!!!!

glorpiness rating: 🌳🌲🌵🌴🌱🌿🪴🎍🍀☘️🍃🎋🪻🥀🌹🌷💐🌾🌼🌺🌸🪷🥦

according to where I found d these images, they're from the florida museum of natural history, but I can't find a link to that with these images so I'll just link the page I found these first instead

I love how this thing is a snail